Related Experiment Video
Updated: Jun 16, 2026
09:56
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Targeting liposomes toward novel pediatric anticancer therapeutics
Noah Federman1, Christopher T Denny
1Division of Pediatric Hematology/Oncology, Gwynne Hazen Cherry Memorial Laboratories, Los Angeles, California 90095, USA. nfederman@mednet.ucla.edu
Pediatric Research
|February 2, 2010
Summary
Nanoparticle drug delivery systems, particularly liposomes, show promise for improving pediatric cancer treatment efficacy while reducing side effects. This review explores strategies, challenges, and future directions for these advanced therapeutic tools.
Area of Science:
- Oncology
- Nanomedicine
- Drug Delivery
Background:
- Modern pediatric cancer treatments improve cure rates but cause significant morbidity.
- Targeted therapies using nanoparticles offer a promising approach to enhance efficacy and minimize toxicity.
- Liposomes are flexible delivery vehicles being explored for encapsulating anticancer agents.
Purpose of the Study:
- To review current strategies for developing nanoparticle-based therapeutic tools for pediatric cancer.
- To emphasize the use of liposomes as versatile delivery vehicles.
- To summarize potential strengths and technical challenges of nanoparticle delivery systems.
Main Methods:
- Review of current literature on nanoparticle drug delivery in pediatric oncology.
- Focus on liposome-based systems for encapsulating anticancer agents.
- Analysis of functional determinants and future strategies for nanoparticle efficacy and specificity.
Main Results:
- Nanoparticle encapsulation, especially with liposomes, holds promise for targeted cancer therapy.
- Identified key functional determinants influencing nanoparticle delivery system performance.
- Summarized potential strengths and technical difficulties in advancing liposome platforms.
Conclusions:
- Liposome-based nanoparticle drug delivery systems offer a promising strategy to improve pediatric cancer treatment outcomes.
- Further research is needed to overcome technical challenges and optimize nanoparticle systems for enhanced efficacy and specificity.
- Targeted nanoparticle therapies represent a significant advancement in reducing treatment-related morbidity in pediatric cancer patients.
More Related Videos
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...